460 related articles for article (PubMed ID: 10023678)
21. Interleukin-2 expression in human carcinoma cell lines and its role in cell cycle progression.
Reichert TE; Nagashima S; Kashii Y; Stanson J; Gao G; Dou QP; Whiteside TL
Oncogene; 2000 Jan; 19(4):514-25. PubMed ID: 10698521
[TBL] [Abstract][Full Text] [Related]
22. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.
Fan S; el-Deiry WS; Bae I; Freeman J; Jondle D; Bhatia K; Fornace AJ; Magrath I; Kohn KW; O'Connor PM
Cancer Res; 1994 Nov; 54(22):5824-30. PubMed ID: 7954409
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.
Schreiber M; Muller WJ; Singh G; Graham FL
Oncogene; 1999 Mar; 18(9):1663-76. PubMed ID: 10208428
[TBL] [Abstract][Full Text] [Related]
24. Unmasking by soluble IL-6 receptor of IL-6 effect on metastatic melanoma: growth inhibition and differentiation of B16-F10.9 tumor cells.
Oh JW; Katz A; Harroch S; Eisenbach L; Revel M; Chebath J
Oncogene; 1997 Jul; 15(5):569-77. PubMed ID: 9247310
[TBL] [Abstract][Full Text] [Related]
25. Anticarcinogenic effect of a flavonoid antioxidant, silymarin, in human breast cancer cells MDA-MB 468: induction of G1 arrest through an increase in Cip1/p21 concomitant with a decrease in kinase activity of cyclin-dependent kinases and associated cyclins.
Zi X; Feyes DK; Agarwal R
Clin Cancer Res; 1998 Apr; 4(4):1055-64. PubMed ID: 9563902
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-6-resistant melanoma cells exhibit reduced activation of STAT3 and lack of inhibition of cyclin E-associated kinase activity.
Böhm M; Schulte U; Funk JO; Raghunath M; Behrmann I; Kortylewski M; Heinrich PC; Kues T; Luger TA; Schwarz T
J Invest Dermatol; 2001 Jul; 117(1):132-40. PubMed ID: 11442760
[TBL] [Abstract][Full Text] [Related]
27. Epidermal growth factor increases the level of the cyclin-dependent kinase (CDK) inhibitor p21/CIP1 (CDK-interacting protein 1) in A431 cells by increasing the half-lives of the p21/CIP1 transcript and the p21/CIP1 protein.
Johannessen LE; Knardal SL; Madshus IH
Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):599-606. PubMed ID: 9895307
[TBL] [Abstract][Full Text] [Related]
28. p27Kip1: a key mediator of retinoic acid induced growth arrest in the SMS-KCNR human neuroblastoma cell line.
Matsuo T; Thiele CJ
Oncogene; 1998 Jun; 16(25):3337-43. PubMed ID: 9681834
[TBL] [Abstract][Full Text] [Related]
29. Modulation of the p27kip1 cyclin-dependent kinase inhibitor expression during IL-4-mediated human B cell activation.
Blanchard DA; Affredou MT; Vazquez A
J Immunol; 1997 Apr; 158(7):3054-61. PubMed ID: 9120257
[TBL] [Abstract][Full Text] [Related]
30. Defects in p21WAF1/CIP1, Rb, and c-myc signaling in phorbol ester-resistant cancer cells.
Blagosklonny MV; Prabhu NS; El-Deiry WS
Cancer Res; 1997 Jan; 57(2):320-5. PubMed ID: 9000576
[TBL] [Abstract][Full Text] [Related]
31. Genistein induces p21(Cip1/WAF1) expression and blocks the G1 to S phase transition in mouse fibroblast and melanoma cells.
Kuzumaki T; Kobayashi T; Ishikawa K
Biochem Biophys Res Commun; 1998 Oct; 251(1):291-5. PubMed ID: 9790949
[TBL] [Abstract][Full Text] [Related]
32. The CDK inhibitor, p27Kip1, is required for IL-4 regulation of astrocyte proliferation.
Liu J; Flanagan WM; Drazba JA; Estes ML; Barnett GH; Haqqi T; Kondo S; Barna BP
J Immunol; 1997 Jul; 159(2):812-9. PubMed ID: 9218599
[TBL] [Abstract][Full Text] [Related]
33. Butyrate-induced differentiation of Caco-2 cells is associated with apoptosis and early induction of p21Waf1/Cip1 and p27Kip1.
Litvak DA; Evers BM; Hwang KO; Hellmich MR; Ko TC; Townsend CM
Surgery; 1998 Aug; 124(2):161-9; discussion 169-70. PubMed ID: 9706134
[TBL] [Abstract][Full Text] [Related]
34. Effects of ectopic overexpression of p21(WAF1/CIP1) on aneuploidy and the malignant phenotype of human brain tumor cells.
Chen J; Willingham T; Shuford M; Bruce D; Rushing E; Smith Y; Nisen PD
Oncogene; 1996 Oct; 13(7):1395-403. PubMed ID: 8875977
[TBL] [Abstract][Full Text] [Related]
35. Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells.
Klausen P; Pedersen L; Jurlander J; Baumann H
Oncogene; 2000 Jul; 19(32):3675-83. PubMed ID: 10951574
[TBL] [Abstract][Full Text] [Related]
36. Cyclin E overexpression responsible for growth of human hepatic tumors with p21WAF1/CIP1/SDI1.
Tsuji T; Miyazaki M; Fushimi K; Mihara K; Inoue Y; Ohashi R; Ohtsubo M; Hamazaki K; Furusako S; Namba M
Biochem Biophys Res Commun; 1998 Jan; 242(2):317-21. PubMed ID: 9446792
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of G1 cyclins and cyclin-dependent kinase inhibitors in normal and transformed melanocytes.
Mouriaux F; Casagrande F; Pillaire MJ; Manenti S; Malecaze F; Darbon JM
Invest Ophthalmol Vis Sci; 1998 May; 39(6):876-84. PubMed ID: 9579467
[TBL] [Abstract][Full Text] [Related]
38. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation.
Albino AP; Juan G; Traganos F; Reinhart L; Connolly J; Rose DP; Darzynkiewicz Z
Cancer Res; 2000 Aug; 60(15):4139-45. PubMed ID: 10945621
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of basic fibroblast growth factor in MCF-7 human breast cancer cells: lack of correlation between inhibition of cell growth and MAP kinase activation.
Wieder R; Fenig E; Wang H; Wang Q; Paglin S; Menzel T; Gabrilove J; Fuks Z; Yahalom J
J Cell Physiol; 1998 Dec; 177(3):411-25. PubMed ID: 9808150
[TBL] [Abstract][Full Text] [Related]
40. The accumulation of cyclin-dependent kinase inhibitor p27kip1 is a primary response to staurosporine and independent of G1 cell cycle arrest.
Nishi K; Schnier JB; Bradbury EM
Exp Cell Res; 1998 Sep; 243(2):222-31. PubMed ID: 9743582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
